Duchenne muscular dystrophy (DMD) is the most common form of muscular dystrophy in
childhood. Mutations of the DMD gene destabilize the dystrophin associated glycoprotein …

Treatment for DMD is a rapidly changing field. Some of the drugs that are currently under
investigation will receive Food and Drug Administration approval in the near future. These …

Duchenne muscular dystrophy (DMD) is the most common and severe childhood muscular
dystrophy, resulting in progressive muscle weakness and wasting, disability and decreased …

Purpose of review The purpose of this review is to summarize the current and emerging
therapies for Duchenne muscular dystrophy (DMD). Recent findings Coinciding with new …

Duchenne muscular dystrophy (DMD) is a monogenic muscle-wasting disorder and a
priority candidate for molecular and cellular therapeutics. Although rare, it is the most …

Duchenne muscular dystrophy (DMD) is the most common childhood form of muscular
dystrophy. It is caused by mutations in the DMD gene, leading to reduced or absent …

Introduction Duchenne muscular dystrophy (DMD) is a devastating, progressive
neuromuscular disorder for which there is no cure. As the dystrophin gene is located on the …

Duchenne muscular dystrophy (DMD) is the most common childhood muscular dystrophy
affecting~ 1: 5000 live male births. Following the identification of pathogenic variations in the …

Duchenne muscular dystrophy (DMD) is a severe and fatal muscle condition affecting young
children. Without interventions, affected boys lose the ability to walk independently by the …

Duchene Muscular Dystrophy (DMD) is the most frequent muscular dystrophy and one of the
most severe due to the absence of the dystrophin protein. Typical pathological features …